NT-proBNP and the diagnosis of heart failure: A pooled analysis of three European epidemiological studies

European Journal of Heart Failure

Volumn 6, Issue 3, 2004, Pages 269-273

  McDonagh, T A ^a   Holmer, S ^b   Raymond, I ^c   Luchner, A ^b   Hildebrant, P ^c   Dargie, H J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c Mental Health Services CPH   (Denmark)

Author keywords

Cardio renal distress; Epidemiological studies; Heart failure

Indexed keywords

BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE; LOOP DIURETIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DYSPNEA; EUROPE; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC STUDIES; EUROPE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 1342312426     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.01.010     Document Type: Article

References (17)

1. Davis M., Espiner E., Richards G., Billings J., Town I., Neill A., et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet. 343:1994;440-444.
2. Choy A.M., Darbar D., Lang C.C., Pringle T.H., McNeill G.P., Kennedy N.S.J., et al. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. Brit Heart J. 72:1994;16-22.
3. Cowie M.R., Struthers A.D., Wood D.A., Coats A.S., Thompson S.G., PooleWilson P.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 350:1997;1349-1353.
4. McDonagh T.A., Robb S.D., Murdoch D.R., Morton J.J., Ford I., Morrison C.E., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 351:(9095):1998;9-13. see comments.
5. Richards A.M., Nicholls G., Yandle T.G., Frampton C., Espiner E.A., Turner J.G., et al. Plasma N-Terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predicitors of left ventricular function and prognosis after myocardial infarction. Circulation. 97:1921-1929;1998.
6. Talwar S., Squire I.B., Downie P.F., Mccullough A.M., Campton M.C., Davies J.E., et al. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction. Eur Heart J. 21:(18):2000;1514-1521.
7. Hobbs F.D., Davis R.C., Roalfe A.K., Hare R., Davies M.K., Kenkre J.E. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. Brit Med J. 324:(7352):2002;1498.
8. Luchner A., Hengstenberg C., Lowel H., Trawinski J., Baumann M., Riegger G.A., et al. N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function. Hypertension. 39:(1):2002;99-104.
9. McDonagh T.A., Morrison C.E., Lawrence A., Ford I., Tunstallpedoe H., McMurray J.J.V., et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 350:1997;829-833.
10. Raymond I., Pedersen F., Steensgaard-Hansen F., Green A., Busch-Sorensen M., Tuxen C., et al. Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen. Heart. 89:(12):2003;1422-1429.
11. Hanley J.A., McNeill B.J. The meaning and use of the area under a receiver operator characteristic (ROC) curve. Radiology. 143:1982;29-36.
12. McCullough P.A., Nowak R.M., McCord J., Hollander J.E., Herrmann H.C., Steg P.G., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 106:(4):2002;416-422.
13. Clerico A. The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex. Clin Chem Lab Med. 40:2002;371-377. Del Ry, S, Maffei, S, Prontera, C, Emdin, M, Giannessi, D.
14. Raymond I., Groenning B.A., Hildebrandt P.R., Nilsson J.C., Baumann M., Trawinski J., et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart. 89:(7):2003;745-751.
15. Sagnella G.A. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci. 95:1998;519-529.
16. Tsutamoto T., Wada A., Maeda K., Hisanga T., Maeda Y., Fukai D., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure - Prognostic role of brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 96:1997;509-516.
17. McDonagh T.A., Cunningham A.D., Morrison C.E., McMurray J.J., Ford I., Morton J.J., et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart. 86:(1):2001;21-26.